GW & Wade’s Verastem VSTM Stock Holding History

GW & Wade’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-958	Closed	-$5K	–	402
2023 Q1	$5K	Hold	958	–	–	﹤0.01%	374
2022 Q4	$5K	Hold	958	–	–	﹤0.01%	383
2022 Q3	$10K	Hold	958	–	–	﹤0.01%	379
2022 Q2	$13K	Hold	958	–	–	﹤0.01%	382
2022 Q1	$16K	Hold	958	–	–	﹤0.01%	390
2021 Q4	$24K	Hold	958	–	–	﹤0.01%	388
2021 Q3	$35K	Hold	958	–	–	﹤0.01%	379
2021 Q2	$47K	Hold	958	–	–	﹤0.01%	381
2021 Q1	$28K	Hold	958	–	–	﹤0.01%	354
2020 Q4	$24K	Hold	958	–	–	﹤0.01%	305
2020 Q3	$14K	Hold	958	–	–	﹤0.01%	240
2020 Q2	$20K	Buy	+958	New	+$25.3K	﹤0.01%	241

Other funds holding VSTM

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

GW & Wade's VSTM Position: Q2 2023 in Review

GW & Wade sold out of Verastem (VSTM) in Q2 2023, closing a stake of 958 shares — an estimated $5K sold.

GW & Wade first reported a position in VSTM in Q2 2020 and held it in 12 quarters. The position peaked at $47K in Q2 2021. 61 funds tracked by Wall St. Rank hold VSTM as of Q2 2023.

GW & Wade reported no remaining Verastem position as of Q2 2023 after selling out during the quarter.
GW & Wade sold 958 Verastem shares in Q2 2023, an estimated $5K.
GW & Wade first reported a position in Verastem in Q2 2020 and held it in 12 quarters.
GW & Wade's Verastem position peaked at $47K in Q2 2021.
61 funds tracked by Wall St. Rank held Verastem as of Q2 2023.

Based on GW & Wade's 13F filing for Q2 2023, filed 10 Aug 2023.